Senate Democrats Optimistic About Passing Drug Pricing Bill Before August Recess

Rachel Cohrs and Sen. Ron Wyden headshots
Senate Finance Chair Ron Wyden (right) said yesterday during a webinar moderated by STAT correspondent Rachel Cohrs (left) that Senate Democrats want to pass drug pricing legislation "right now, before everybody leaves for August."

U.S. Senate Democrats are hopeful that drug pricing legislation will be passed by early next month via a budget reconciliation process requiring just 50 Democratic votes, a Democratic source with knowledge of the process told 340B Report.

“Our expectation is, we’re

Read More »

AHF Sues Express Scripts Over Medicare Part D Reimbursement Claw Backs

Metal claw
AIDS Healthcare Foundation accuses Express Scripts of using its market power to wrongly claw back millions of dollars in Medicare drug reimbursement from pharmacies.

Pharmacy benefits manager Express Scripts unfairly uses a Medicare pharmacy ratings system to wrongly claw back millions of dollars in drug reimbursement from pharmacies participating in the Medicare Part D prescription drug program, AIDS Healthcare Foundation (AHF) alleges in a

Read More »

In Effort to Rein in High Prices, Another Big Player Jumps into the Insulin Market

Screenshot of Gov. Gavin Newsom in a television address
California Gov. Gavin Newsom (D) announced in a video message on Twitter that the state set aside $100 million to develop and manufacture its own low-cost insulin.

California will start making its own insulin under a state budget bill Gov. Gavin Newsom (D) signed June 30.

The bill includes $50 million to develop three low-cost biosimilar insulin products and another $50 million for a California-based insulin-manufacturing facility.

Read More »

100 Congressional Democrats Urge HHS to Use Existing Power to Lower Drug Prices

soldiers marching in formation on parade ground
Congressional Democrats want HHS to use march-in rights and other existing authority to lower drug prices.

The U.S. Department of Health and Human Services should swiftly use its existing statutory authority—including forcing drug patent owners to license their products to others—to lower drug prices, 100 Democratic members of Congress urged HHS Secretary Xavier Becerra late last

Read More »

Schumer Pledges to Hold Senate Vote Soon on New Bill to Make Insulin More Affordable

Sen, Susan Collins (R-ME) speaking at a podium
U.S. Sens. Susan Collins (R-Maine), left, and Jeanne Shaheen (D-N.H.) introduced bipartisan legislation to make insulin more affordable.

A new bipartisan bill to make insulin more affordable for patients could be up for a U.S. Senate vote as early as next month. There are doubts the bill will get enough Republican support to pass, however, dooming it to

Read More »

PhRMA and Private Oncology Practices Slam PBMs’ Role in 340B in Comments to FTC

Federal Trade Commission sign over entrance.
The FTC and HHS asked for stakeholder feedback on generic drug shortages, which could have implications for the 340B program.

Growth in 340B covered entities’ use of contract pharmacies to dispense 340B drugs, coupled with growth in pharmacy benefit managers’ control over these pharmacies, has given PBMs an outsized, profit-driven role in the 340B program that does not benefit patients,

Read More »

NACHC Hopes Congress Will Pass Laws Protecting 340B Providers This Year

screenshot of Joe Dunn with NACHC brand background
NACHC “would love to see” Congress pass legislation by the end of this year protecting health centers from drug manufacturers and PBMs' restrictions on 340B access, NACHC Senior Vice President Joe Dunn said during a news conference yesterday.

The National Association of Community Health Centers “would love to see” Congress pass legislation by the end of this year that stops drug makers from restricting 340B contract pharmacy arrangements and stops pharmacy benefit managers from taking covered entities’ 340B savings, a NACHC

Read More »

FTC To Investigate PBMs’ Impact on Drug Access and Affordability

screenshot of FTC inquiry on pharmacy benefit managers
Under pressure from small pharmacies, drug makers, 340B providers, and others, the FTC agreed to "shine a light" on PBMs' business practices and their impact on pharmacies, payers, doctors, and patients.

Just months after deadlocking, the U.S. Federal Trade Commission voted unanimously on Tuesday to launch an investigation into pharmacy benefit managers’ business practices to assess their impact on prescription drug access and affordability.

Groups that represent 340B health care providers 

Read More »

In a Move to Expand its Specialty Pharmacy Services, CPS Acquires Trellis Rx

Frank Segrave and Andy Maurer headshots
CPS Chairman & CEO Frank Segrave (left) says his company's acquisition of Trellis Rx "helps us to deliver a broader range of offerings and flexibility across our inpatient and outpatient businesses." Trellis co-founder and CEO Andy Maurer (right) says the companies "complement each other and together, we can create a more diverse offering across inpatient, outpatient and specialty pharmacy settings for health and hospital systems serving communities of all sizes."

340B pharmacy and health-system services provider CPS Solutions, based in Dublin, Ohio, announced late last week that it has acquired specialty pharmacy services company Trellis Rx, headquartered in Atlanta, Ga.

Both companies have personnel with several decades of 340B experience.

Read More »

Groups Blast PBMs’ Discrimination Against 340B Hospitals in Letters to FTC

Federal Trade Commission building
Groups that represent or work with 340B hospitals urged the FTC to take a closer look at PBMs' alleged discriminatory business practices.

Pharmacy benefit managers’ discriminatory business practices against 340B hospitals boost PBMs’ financial bottom lines while hurting the hospitals’ mission to serve vulnerable patients, groups that represent or work with 340B hospitals and their pharmacists recently told the Federal Trade Commission

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live